Novo Nordisk Pushes Deeper Into Obesity Science as Washington’s Pricing Hammer Looms
Novo Nordisk launches Phase 3 trial of Amycretin to prevent weight regain after diet, while a US drug…
Novo Nordisk’s One-Time Windfall Masks a Deeper Squeeze as Pipeline Bets Take Shape
Novo Nordisk’s Q1 profit surged on a one-off accounting gain, but US sales fell 11% amid pricing pressure.…